Overview This page contains the latest trade data of Vaccines, human use. In 2020, Vaccines, human use were the world's 69th most traded product, with a total trade of $32.6B. Between 2019 and 2020 the exports of Vaccines, human use grew by 1.11%, from $32.3B to $32.6B. Trade in Vaccines, human use represent 0.19% of total world trade.
Vaccines, human use are a part of Blood, antisera, vaccines, toxins and cultures.
Exports In 2020 the top exporters of Vaccines, human use were Belgium ($11.4B), Ireland ($6.07B), France ($4.41B), United States ($2.03B), and Italy ($1.7B).
Imports In 2020 the top importers of Vaccines, human use were Belgium ($7.58B), United States ($7.46B), Germany ($1.69B), China ($1.41B), and United Kingdom ($1.22B).
Tariffs In 2018 the average tariff for Vaccines, human use was 0.86%, making it the 6418th lowest tariff using the HS6 product classification.
The countries with the highest import tariffs for Vaccines, human use are French Polynesia (13.4%), Democratic Republic of the Congo (10%), India (8.18%), and Aruba (6%). The countries with the lowest tariffs are Angola (0%), Cote d'Ivoire (0%), Algeria (0%), Egypt (0%), and Ethiopia (0%).
Ranking Vaccines, human use ranks 1174th in the Product Complexity Index (PCI).
Description A vaccine is a substance that creates immunity against a disease. It is typically administered by injection, but may be administered orally or by aerosol. Vaccines can protect against many infectious diseases including measles, mumps, tetanus, polio, rubella, and hepatitis A.